1. Home
  2. ABCL vs DSL Comparison

ABCL vs DSL Comparison

Compare ABCL & DSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.51

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo DoubleLine Income Solutions Fund of Beneficial Interests

DSL

DoubleLine Income Solutions Fund of Beneficial Interests

HOLD

Current Price

$10.73

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
DSL
Founded
2012
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
ABCL
DSL
Price
$3.51
$10.73
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.75
N/A
AVG Volume (30 Days)
2.3M
618.2K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
12.20%
EPS Growth
10.91
N/A
EPS
N/A
N/A
Revenue
$75,128,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$25.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
160.56
N/A
52 Week Low
$1.89
$10.49
52 Week High
$6.52
$12.67

Technical Indicators

Market Signals
Indicator
ABCL
DSL
Relative Strength Index (RSI) 53.38 39.71
Support Level $3.37 N/A
Resistance Level $3.57 $11.45
Average True Range (ATR) 0.15 0.14
MACD 0.01 0.01
Stochastic Oscillator 65.63 31.82

Price Performance

Historical Comparison
ABCL
DSL

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About DSL DoubleLine Income Solutions Fund of Beneficial Interests

DoubleLine Income Solutions Fund is a closed-end management investment company. Its primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in debt securities and other income-producing investments anywhere in the world, including emerging markets. The company's investment portfolio comprises foreign corporate bonds, U.S. corporate bonds, bank loans, collateralized loan obligations, non-agency commercial mortgage backed obligations, asset-backed obligations, and municipal bonds among others.

Share on Social Networks: